|
WO2005004794A2
(en)
*
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals Inc. |
Method of treating neurodegenerative disease
|
|
WO2005045034A2
(en)
*
|
2003-10-23 |
2005-05-19 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA)
|
|
EP1799826B1
(en)
*
|
2004-09-29 |
2009-08-12 |
Children's Memorial Hospital |
siRNA-MEDIATED GENE SILENCING OF ALPHA SYNUCLEIN
|
|
PT3272872T
(pt)
|
2005-10-20 |
2020-06-26 |
Uniqure Ip Bv |
Vetores aav melhorados produzidos em células de insetos
|
|
WO2007148971A2
(en)
|
2006-06-21 |
2007-12-27 |
Amsterdam Molecular Therapeutics B.V. |
Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
|
|
HUE029744T2
(en)
|
2007-07-26 |
2017-04-28 |
Uniqure Ip Bv |
Baculoviral vectors comprising repeated coding sequences with differential codon biases
|
|
US20090176729A1
(en)
*
|
2007-12-14 |
2009-07-09 |
Alnylam Pharmaceuticals, Inc. |
Method of treating neurodegenerative disease
|
|
AU2009215987B2
(en)
|
2008-02-19 |
2015-01-22 |
Uniqure Ip B.V. |
Optimisation of expression of parvoviral rep and cap proteins in insect cells
|
|
WO2010129791A1
(en)
*
|
2009-05-06 |
2010-11-11 |
University Of Medicine And Dentistry Of New Jersey |
Rna targeting in alpha-synucleinopathies
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
PT2561078T
(pt)
*
|
2010-04-23 |
2018-12-03 |
Cold Spring Harbor Laboratory |
Sharn com uma conceção estrutural inovadora
|
|
EP3521451A1
(en)
*
|
2010-11-17 |
2019-08-07 |
Ionis Pharmaceuticals, Inc. |
Modulation of alpha synuclein expression
|
|
JP6198278B2
(ja)
|
2011-09-08 |
2017-09-20 |
ユニキュアー アイピー ビー.ブイ. |
Aav調製物からの混入ウイルスの除去
|
|
AU2015370903B2
(en)
|
2014-12-24 |
2021-06-17 |
Uniqure Ip B.V. |
RNAi induced huntingtin gene suppression
|
|
US11046955B2
(en)
*
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
MX2020004005A
(es)
*
|
2017-10-03 |
2020-10-05 |
Prevail Therapeutics Inc |
Terapias genicas para los trastornos lisosomales.
|
|
TW202509215A
(zh)
*
|
2018-08-03 |
2025-03-01 |
美商健臻公司 |
針對α-突觸核蛋白的變體RNAi
|
|
WO2020104295A1
(en)
*
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3
|
|
AU2019385638A1
(en)
*
|
2018-11-19 |
2021-06-03 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
|
US11827880B2
(en)
*
|
2019-12-02 |
2023-11-28 |
Shape Therapeutics Inc. |
Therapeutic editing
|